PropertyValue
?:definition
  • Immunoassay reagents intended to perform qualitative and/or quantitative analyses on a body fluid sample (typically urine) to determine substances present in or secreted by neoplastic urinary bladder tumor cells (i.e., tumor markers); these reagents include antibodies capable of binding to the urinary bladder tumor associated antigens such as complement factor H related protein, fragments of cytokeratines 8 and 18, or nuclear mitotic apparatus protein NMP22. These assays are used to obtain information on tumor grade and clinical stage of urothelial carcinomas of the bladder.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C3690853_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C3690853_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all